Laura Huidobro, Anna Domingo, Elvira Gómez, Albert Serrà
{"title":"Bismuth oxyiodide-based composites for advanced visible-light activation of peroxymonosulfate in pharmaceutical mineralization.","authors":"Laura Huidobro, Anna Domingo, Elvira Gómez, Albert Serrà","doi":"10.1016/j.chemosphere.2024.143532","DOIUrl":null,"url":null,"abstract":"<p><p>The presence of pharmaceutical pollutants in water bodies represents a significant environmental and public health concern, largely due to their inherent persistence and potential to induce antibiotic resistance. Advanced oxidation processes (AOPs) that employ peroxymonosulfate (PMS) activation have emerged as an effective means of degrading these contaminants. Bismuth oxyiodides (BiOI), which are known for their visible-light photocatalytic properties, demonstrate considerable potential for removal of pharmaceutical pollutants. This study examines the synthesis and performance of BiOI-based composites with barium ferrite (BFO) nanoparticles for enhanced PMS activation under visible light. BiOI and Bi<sub>5</sub>O<sub>7</sub>I were synthesized via solvothermal and electrodeposition methods, respectively, and their morphologies and crystalline structures were observed to exhibit distinctive characteristics following annealing. The formation of the composite with BFO resulted in an improvement in the catalytic properties, which in turn enhanced the surface area and availability of active sites. The objective of the photocatalytic studies was to evaluate the degradation and mineralization of tetracycline (TC) under visible light, PMS, and combined conditions. The Bi<sub>5</sub>O<sub>7</sub>I(ED)-BFO catalyst was identified as the optimal candidate, achieving up to 99.8% TC degradation and 99.4% mineralization within 90 min at room temperature. The synergistic effect of BFO in BiOI-based composites significantly enhanced performance across all conditions, indicating their potential for efficient remediation of pharmaceutical pollutant. The material's performance was further evaluated in tap water, where the degradation efficiency decreased to 56.4% and mineralization to 38.2%. These results reflect the challenges posed by complex water matrices. However, doubling the PMS concentration to 5 mM led to improved outcomes, with 93.8% degradation and 81.4% mineralization achieved. These findings demonstrate the material's robust potential for treating pharmaceutical pollutants in real-world conditions, advancing sustainable water treatment technologies.</p>","PeriodicalId":93933,"journal":{"name":"Chemosphere","volume":"366 ","pages":"143532"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemosphere","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.chemosphere.2024.143532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The presence of pharmaceutical pollutants in water bodies represents a significant environmental and public health concern, largely due to their inherent persistence and potential to induce antibiotic resistance. Advanced oxidation processes (AOPs) that employ peroxymonosulfate (PMS) activation have emerged as an effective means of degrading these contaminants. Bismuth oxyiodides (BiOI), which are known for their visible-light photocatalytic properties, demonstrate considerable potential for removal of pharmaceutical pollutants. This study examines the synthesis and performance of BiOI-based composites with barium ferrite (BFO) nanoparticles for enhanced PMS activation under visible light. BiOI and Bi5O7I were synthesized via solvothermal and electrodeposition methods, respectively, and their morphologies and crystalline structures were observed to exhibit distinctive characteristics following annealing. The formation of the composite with BFO resulted in an improvement in the catalytic properties, which in turn enhanced the surface area and availability of active sites. The objective of the photocatalytic studies was to evaluate the degradation and mineralization of tetracycline (TC) under visible light, PMS, and combined conditions. The Bi5O7I(ED)-BFO catalyst was identified as the optimal candidate, achieving up to 99.8% TC degradation and 99.4% mineralization within 90 min at room temperature. The synergistic effect of BFO in BiOI-based composites significantly enhanced performance across all conditions, indicating their potential for efficient remediation of pharmaceutical pollutant. The material's performance was further evaluated in tap water, where the degradation efficiency decreased to 56.4% and mineralization to 38.2%. These results reflect the challenges posed by complex water matrices. However, doubling the PMS concentration to 5 mM led to improved outcomes, with 93.8% degradation and 81.4% mineralization achieved. These findings demonstrate the material's robust potential for treating pharmaceutical pollutants in real-world conditions, advancing sustainable water treatment technologies.